Reduced Physical Activity for Sedentary Lifestyle
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot take more than 500mg of vitamins daily or use acetaminophen or aspirin during the study.
What data supports the effectiveness of the treatment Reduced Physical Activity for a sedentary lifestyle?
Is reduced physical activity safe for humans?
How does the treatment 'Reduced Physical Activity' differ from other treatments for a sedentary lifestyle?
The treatment 'Reduced Physical Activity' is unique because it focuses on decreasing the amount of time spent sitting or being inactive, rather than increasing exercise levels. This approach is based on emerging evidence that excessive sitting is a health risk on its own, and reducing sedentary time can improve health even if physical activity levels remain the same.1011121314
What is the purpose of this trial?
The far-reaching negative health effects of the reduced physical activity (RPA) epidemic are often overlooked by the general population and health professionals. Short-term RPA induces cardiometabolic dysfunction, including impaired glucose control and vascular function, that may precede disease development. The impact of existing health status on RPA-induced cardiometabolic dysfunction and recovery of impaired glucose control following RPA is unexplored. Thus, the investigators' objectives are 1) to investigate the effect of existing health status (cardiorespiratory fitness and adiposity) on the recovery of impaired glucose control following a period of RPA and 2) to determine the role of vascular function as a mechanism of impaired glucose control. The investigators' final objective is to 3) expose undergraduate students to meritorious biomedical clinical research methods. The investigators have piloted the clinical research methods and analysis with undergraduate researcher associates and are well-prepared to complete this proposal. Preliminary data show that low cardiorespiratory fitness and/or high adiposity impair the recovery of glucose control following short-term RPA. Thus, the investigators aim to examine the interactive role of health status (cardiorespiratory fitness and adiposity) on the ability to recover impaired glucose control following short-term RPA. The investigators also seek to examine changes in vascular function as a mechanism of recovery of impaired glucose control following a return to normal PA. The investigators will recruit men and women with divergent health status (cardiorespiratory fitness and adiposity) to examine glucose control and vascular function during 7-d of normal PA, 7-d of RPA, and 7-d of resumption of normal RA. Continuous glucose monitoring and oral glucose tolerance tests will be performed to assess glucose control. Increases in vascular shear stress induced by passive leg movement and central arterial stiffness will be measured to assess vascular function.
Eligibility Criteria
This trial is for men and women with varying levels of fitness and body fat. It's designed to see how these factors affect blood sugar control after a period of reduced physical activity (like sitting too much). Participants should be generally healthy but may have different exercise habits or weights.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Normal Physical Activity
Participants maintain their normal level of physical activity
Reduced Physical Activity
Participants reduce their physical activity by at least 2000 steps per day using strategies such as seated electric scooters
Resumption of Normal Physical Activity
Participants resume their normal physical activity levels
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- Reduced Physical Activity
Find a Clinic Near You
Who Is Running the Clinical Trial?
Miami University
Lead Sponsor